Can a pill shield vulnerable transplant patients from deadly fungus?
NCT ID NCT04725942
Summary
This study aimed to see if the drug posaconazole, given as a tablet, is safe and effective at preventing serious fungal infections in the lungs of patients who have received a stem cell transplant. Researchers observed 360 transplant patients in China who took the drug for about 3 months after their procedure. They checked drug levels in the blood and tracked whether patients developed infections to understand how well the prevention worked.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY FUNGAL INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, China
-
Shanxi Bethune Hospital
Taiyuan, China
-
The Second Hospital of Hebei Medical University
Shijia Zhuang, China
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
Conditions
Explore the condition pages connected to this study.